Editorial board

EDITOR-IN-CHIEF

Naim Alkhouri - Texas Liver Institute, San Antonio, Texas, USA

ASSOCIATE EDITORS 

Jerry Colca - Kalamazoo Metabolic Research, MI, USA 

EDITOR-IN-CHIEF EMERITUS

Giuseppe Tonini - University Campus Bio-Medico, Italy

EDITORIAL ADVISORY BOARD

Karl-Eric Andersson - Wake Forest University, NC, USA
Wilbert Aronow - New York Medical College, NY , USA
Guglielmo Borgia - University of Naples Federico II, Italy
Martin Braddock - AstraZeneca, Loughborough, England, UK
Maria Luisa Brandi - University of Florence, Italy
Linda Cardozo - King's College London, England, UK
Thomas Ciulla - Indiana University School of Medicine, Indianapolis, IN, USA
Mellar Davis - Taussig Cancer Institute, OH, USA
William Denny - University of Auckland, New Zealand
Nafsika Georgopapadakou - MethylGene, Montreal, Canada
Lars Grundemar - Ferring Pharmaceuticals, Denmark
Percy Ivy – National Cancer Institute, MD, USA
Michael Koutsilieris - University of Athens, Greece
Renu Kowluru - Kresge Eye Institute, MI, USA
Dimitri Mikhalidis - University College London, England, UK
Nouri Naemati - University of Southern California, CA, USA
Athanasios Papatsoris - University of Athens, Greece
Athanasios Papavassiliou - University of Athens, Greece
Godefridus J. Peters - Amsterdam UMC, The Netherlands
Alessandro Rizzo - S. Orsola-Malpighi University Hospital, Bologna, Italy
Marwan N Sabbagh - Banner Sun Health Research Institute, USA
Tomi Sawyer - Merck Research Laboratories, MA, USA
Nicola Silvestris – Cancer Institute, 'Giovanni Paolo II’, Italy
Noel J Snell - Royal Brompton Hospital, London, England, UK
Guru Sonpavde - Dana Farber Cancer Institute, MA, USA
Christoph Stein - Charité Campus Benjamin Franklin, Berlin, Germany
Eleftherios Tsiridis - Imperial College, London, England, UK
László Vecsei - University of Szeged, Hungary
Stephan von Haehling - University of Göttingen, Germany
Robert Williams - Cancer Research UK